Insights

Acquisition history Ascenta Therapeutics has a notable history of acquisitions involving major players, including Sanofi in 2018 for $398M and Facebook in 2014. This suggests potential openness to strategic partnerships, licensing deals, or co-development arrangements with large pharma or tech-enabled healthcare entities seeking oncology innovation.

Growth opportunity With revenue in the $10M–$25M range and total funding of $88M, the company appears to be a mid-stage biotech with capital runway suitable for milestones tied to collaboration, manufacturing scale-up, or late-stage clinical development support from interested buyers or strategic partners.

Strategic fit The firm operates in pharmaceutical manufacturing and biotechnology, indicating potential fit for supply agreements, contract manufacturing, or technology licensing opportunities that leverage its existing capabilities for scalable production and manufacturing efficiency.

Competitive positioning Given the small employee base (2–10) relative to large peers, partnering opportunities may focus on outsourcing, strategic alliances, or joint ventures with larger CROs or CMOs to accelerate development while leveraging Ascenta’s niche assets.

Market signals Historical acquisitions by Sanofi and Facebook imply strategic interest in oncology and global connectivity initiatives; sales outreach could target oncology drug development channels, digital health integrations, or connectivity-enabled clinical trial solutions that align with broader industry trends.

Similar companies to Ascenta Therapeutics, Inc.

Ascenta Therapeutics, Inc.'s Email Address Formats

Ascenta Therapeutics, Inc. uses at least 1 email format:
Ascenta Therapeutics, Inc. Email FormatsExamplePercentage
FLast@ascenta.comJDoe@ascenta.com
100%

Frequently Asked Questions

What is Ascenta Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Ascenta Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ascenta Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Ascenta Therapeutics, Inc.'s official website is ascenta.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Ascenta Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Ascenta Therapeutics, Inc.'s annual revenue is estimated to be $10M - $25M.

What is Ascenta Therapeutics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Ascenta Therapeutics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Ascenta Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Ascenta Therapeutics, Inc. has approximately 6 employees across 1 continents, including North America. Key team members include Associate Director, Clinical Development: J. M. Explore Ascenta Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Ascenta Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Ascenta Therapeutics, Inc. operates in the Pharmaceutical Manufacturing industry.

What is Ascenta Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Ascenta Therapeutics, Inc.'s email format typically follows the pattern of FLast@ascenta.com. Find more Ascenta Therapeutics, Inc. email formats with LeadIQ.

How much funding has Ascenta Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Ascenta Therapeutics, Inc. has raised $88M in funding. The last funding round occurred on Feb 06, 2010 for $1.8M.
Ascenta Therapeutics, Inc. logo

Ascenta Therapeutics, Inc.

Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees

Ascenta Therapeutics, Inc. is a biotechnology-focused entity operating within the pharmaceutical manufacturing landscape. Based in Malvern, Pennsylvania, the company is described as a biotechnology firm, indicating its work lies at the intersection of biology and therapeutic development aimed at addressing disease. With a small professional footprint, Ascenta is positioned to pursue research and development activities typical of early-stage or specialized biotech ventures within the broader life sciences sector.

The brief company profile situates Ascenta within the United States biotech ecosystem, noting its location and industry alignment. While specific products or service lines are not detailed in the provided information, the organization’s classification and its reference within recent news items imply engagement in cancer-related therapeutic development. The recent developments section references notable industry events involving acquisitions, which contextualize the company’s position within a dynamic market for biotechnology and pharmaceutical innovation in the Malvern region.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $88M

    Ascenta Therapeutics, Inc. has raised a total of $88M of funding over 4 rounds. Their latest funding round was raised on Feb 06, 2010 in the amount of $1.8M as a Debt Financing.

  • $10M - $25M

    Ascenta Therapeutics, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.